Amoxicillin-Clavulanate Tablets 875mg/125mg from Canada
This is a combination antibiotic containing amoxicillin (a penicillin G derivative) and clavulanic acid, put up in measured doses as oral tablets for treating bacterial infections like sinusitis and pneumonia. It falls under HTS 3004.10.10.45 as a combination antibiotic with penicillanic acid structure in retail packaging. The clavulanate inhibits bacterial beta-lactamase, enhancing efficacy.
Duty Rate — Canada → United States
100%
Rate breakdown
9903.04.60100%Pharmaceuticals Annex IV: patented pharma articles — 100% floor rate
9903.05.860%Universal product exemption (U.S. note 52(b))
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Verify FDA approval and provide Certificate of Pharmaceutical Product (CPP) from manufacturer
• Ensure accurate labeling of active ingredients, dosage, and expiry; common pitfall is mismatched batch documentation
• Comply with USP standards for stability; declare exact penicillin G salt content to avoid reclassification